Hemagen Diagnostics, Inc. (HMGN)

Hemagen Diagnostics Cash Flow Statement

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008
Period Ending	Sep 30, 2012	Sep 30, 2011	Sep 30, 2010	Sep 30, 2009	Sep 30, 2008
Net Income	-0.91	-0.88	-0.16	-0.81	0.43
Depreciation & Amortization	0.16	0.19	0.16	0.16	0.11
Other Amortization	-	-	-	0.07	0.07
Loss (Gain) From Sale of Assets	0	-0	-0.03	-0.04	-0.84
Stock-Based Compensation	0.05	0.05	0.04	0.05	0.03
Provision & Write-off of Bad Debts	-0	0.01	-0.01	0.03	0.02
Other Operating Activities	0.05	0.03	-	0.23	0.05
Change in Accounts Receivable	-0.01	0.08	-0.03	0.2	0.12
Change in Inventory	0.11	-0.07	0.3	0.11	0.47
Change in Accounts Payable	0.13	0.08	-0.23	-0.16	-0.2
Change in Unearned Revenue	-0.02	0.01	-0.02	-0.05	0.08
Change in Other Net Operating Assets	0.07	0.18	-0.22	0.23	-0.06
Operating Cash Flow	-0.36	-0.34	-0.18	0.02	0.27
Operating Cash Flow Growth	-	-	-	-93.66%	-
Capital Expenditures	-0.09	-0.06	-0.07	-0.11	-0.37
Sale of Property, Plant & Equipment	-	0	0.04	0.05	0.01
Other Investing Activities	0.04	0.21	0.21	0.21	0.18
Investing Cash Flow	-0.06	0.16	0.18	0.15	-0.18
Short-Term Debt Issued	0.31	0.27	-	-	0.16
Total Debt Issued	0.31	0.27	-	-	0.16
Short-Term Debt Repaid	-	-	-0.03	-0.22	-
Long-Term Debt Repaid	-	-	-	-	-0.12
Total Debt Repaid	-	-	-0.03	-0.22	-0.12
Net Debt Issued (Repaid)	0.31	0.27	-0.03	-0.22	0.04
Financing Cash Flow	0.31	0.27	-0.03	-0.22	0.04
Foreign Exchange Rate Adjustments	-0.04	-0.03	0.03	0.12	-0.03
Net Cash Flow	-0.15	0.06	-0	0.06	0.09
Free Cash Flow	-0.45	-0.39	-0.26	-0.1	-0.1
Free Cash Flow Margin	-11.13%	-7.66%	-4.93%	-1.81%	-1.62%
Free Cash Flow Per Share	-0.03	-0.03	-0.02	-0.01	-0.01
Cash Interest Paid	0.2	0.39	0.37	0.38	0.36
Cash Income Tax Paid	-	0	0.09	0.02	0.13
Levered Free Cash Flow	-0.12	0.11	-0.12	0.34	-0.05
Unlevered Free Cash Flow	0.18	0.36	0.08	0.52	0.11
Change in Working Capital	0.29	0.27	-0.2	0.33	0.41

Source: S&P Global Market Intelligence. Standard template. Financial Sources.